Erratum to "Gangliosides, Ab1 and Ab2 antibodies. II. Light versus heavy chain: An idiotype-anti-idiotype case study" [Mol. Immunol. 44 (2007) 1015-1028] (DOI:10.1016/j.molimm.2006.03.004);Gangliosides, Ab1 and Ab2 antibodies. II. Light versus heavy chain: An idiotype-anti-idiotype case study

Molecular Immunology

Volumn 44, Issue 5, 2007, Pages 1015-1028

  López Requena, Alejandro ^a   Rodríguez, Mabel ^a   de Acosta, Cristina Mateo ^a   Moreno, Ernesto ^a   Puchades, Yaquelin ^b   González, Majela ^a,b   Talavera, Ariel ^a   Valle, Aisel ^a   Hernández, Tays ^a   Vázquez, Ana María ^a   Pérez, Rolando ^a  

^a CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^b CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

Anti idiotypic antibodies; Heavy chain; Light chain; N Glycolyl gangliosides

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1B;

ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CHIMERA; GENETIC ANALYSIS; IMMUNOGENICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 33748774389     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.08.031     Document Type: Erratum

References (40)

1. Akolkar P.N., Sikder S.K., Bhattacharya S.B., Liao J., Gruezo F., Morrison S.L., and Kabat E.A. Different VL and VH germ-line genes are used to produce similar combining sites with specificity for alpha(1-6)dextrans. J. Immunol. 138 (1987) 4472-4479
2. Alfonso M., Díaz A., Hernández A.M., Pérez A., Rodríguez E., Bitton R., Pérez R., and Vázquez A.M. An anti-idiotype vaccine elicits a specific response to N-glycolyl sialic acid residues of glycoconjugates in melanoma patients. J. Immunol. 168 (2002) 2523-2529
3. Alfonso M., Vázquez A.M., Carr A., Haerslev T., Fernández L.E., Lanio M.E., Alvarez C., Zeuthen J., and Pérez R. T-cell independent B-cell response to self monosialogangliosides: primary response monoclonal antibodies. Hybridoma 14 (1995) 209-216
4. Almagro J.C. Identification of differences in the specificity-determining residues of antibodies that recognize antigens of different size: implications for the rational design of antibody repertoires. J. Mol. Recog. 17 (2004) 132-143
5. Bangs L.A., Sanz I.E., and Teale J.M. Comparison of D, JH and junctional diversity in the fetal, adult, and aged B cell repertoires. J. Immunol. 146 (1991) 1996-2004
6. Bhattacharya-Chatterjee M., Chatterjee S.K., and Foon K.A. Anti-idiotype vaccine against cancer. Immunol. Lett. 74 (2000) 51-58
7. Calarese D.A., Scanlan C.N., Zwick M.B., Deechongkit S., Mimura Y., Kunert R., Zhu P., Wormald M.R., Stanfield R.L., Roux K.H., Kelly J.W., Rudd P.M., Dwek R.A., Katinger H., Burton D.R., and Wilson I.A. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300 (2003) 2065-2071
8. Carr A., Mullet A., Mazorra Z., Vázquez A.M., Alfonso M., Mesa C., Rengifo E., Pérez R., and Fernández L.E. A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors. Hybridoma 19 (2000) 241-247
9. Chapman P.B. Vaccinating against GD3 ganglioside using BEC2 anti-idiotypic monoclonal antibody. Curr. Opin. Investig. Drugs 4 (2003) 710-715
10. Díaz A., Alfonso M., Alonso R., Sáurez G., Troche M., Catalá M., Díaz R.M., Pérez R., and Vázquez A.M. Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides. Clin. Immunol. 107 (2003) 80-89
11. Foon K.A., Lutzky J., Baral R.N., Yannelli J.R., Hutchins L., Teitelbaum A., Kashala O.L., Das R., Garrison J., Reisfeld R.A., and Bhattacharya-Chatterjee M. Clinical and immune responses in advanced melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2. J. Clin. Oncol. 18 (2000) 376-384
12. Guex N., and Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18 (1997) 2714-2723. http://www.expasy.org/spdbv/
13. Hamers-Casterman C., Atarhouch T., Muyldermans S., Robinson G., Hamers C., Songa E.B., Bendahman N., and Hamers R. Naturally occurring antibodies devoid of light chains. Nature 363 (1993) 446-448
14. Hashimoto Y., Otsuka H., Sudo K., Suzuki K., and Yamakawa T. Genetic regulation of GM2 expression in liver mouse. J. Biochem. 93 (1983) 895-901
15. Jin H., Sepulveda J., and Burrone O.R. Selection and characterisation of binders based on homodimerisation of immunoglobulin V(H) domains. FEBS Lett. 554 (2003) 323-329
16. Kabat E.A., Wu T.T., Peery H.M., Gottesmann K.S., and Foeller C. Sequences of Proteins of Immunological Interest. fifth ed. (1991), U.S. Department of Health and Human Services, U.S. Government Printing Office, Washington
17. Krengel U., Olsson L.-L., Martínez C., Talavera A., Rojas G., Mier E., Ångström J., and Moreno E. Structure and molecular interactions of a unique anti-tumor antibody specific for N-glycolyl GM3. J. Biol. Chem. 279 (2003) 5597-5603
18. Leahy D.J., Rule G.S., Whittaker M.M., and McConnell H.M. Sequences of 12 monoclonal anti-dinitrophenyl spin-label antibodies for NMR studies. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 3661-3665
19. López-Requena A., De Acosta C.M., Moreno E., González M., Puchades Y., Talavera A., Vispo N.S., Vázquez A.M., and Pérez R. Gangliosides, Ab1 and Ab2 antibodies. I. Towards a molecular dissection of an idiotype-anti-idiotype system. Mol. Immunol. 44 (2007) 423-433
20. López-Requena A., Mateo de Acosta C., Pérez A., Valle A., Lombardero J., Sosa K., Pérez R., and Vázquez A.M. Chimeric anti-N-glycolyl-ganglioside and its anti-idiotypic MAbs: immunodominance of their variable regions. Hybrid. Hybridomics 22 (2003) 235-243
21. Malykh Y.N., Schauer R., and Shaw L. N-Glycolylneuraminic acid in human tumours. Biochimie 83 (2001) 623-634
22. Morea V., Tramontano A., Rustici M., Chothia C., and Lesk A.M. Conformations of the third hypervariable region in the VH domain of immunoglobulins. J. Mol. Biol. 275 (1998) 269-294
23. Noel D., Bernardi T., Navarro-Teulon I., Marin M., Martinetto J.P., Ducancel F., Mani J.C., Pau B., Piechaczyk M., and Biard-Piechaczyk M. Analysis of the individual contributions of immunoglobulin heavy and light chains to the binding of antigen using cell transfection and plasmon resonance analysis. J. Immunol. Methods 193 (1996) 177-187
24. Pérez A., Lombardero J., Mateo C., Mustelier G., Alfonso M., Vázquez A.M., and Pérez R. Immunogenetic analysis of variable regions encoding Ab1 and γ-type Ab2 antibodies from the NeuGc-containing ganglioside family. Hybridoma 20 (2001) 211-221
25. Pérez A., Mier E.S., Santiago N., and Pérez R. A monoclonal antibody against NeuGc-containing gangliosides contains a regulatory idiotope involved in the interaction with B and T cells. Mol. Immunol. 39 (2002) 103-112
26. Reiter Y., Schuck P., Boyd L.F., and Plaksin D. An antibody single-domain phage display library of a native heavy chain variable region: isolation of functional single-domain VH molecules with a unique interface. J. Mol. Biol. 290 (1999) 685-698
27. Rodríguez M., Llanes L., Pérez A., Pérez R., and Vázquez A.M. Generation and characterization of an anti-idiotype monoclonal antibody related to GM3(NeuGc) ganglioside. Hybrid. Hybridomics 22 (2003) 307-314
28. Rojas G., Talavera A., Muñoz Y., Rengifo E., Krengel U., Ångström J., Gavilondo J., and Moreno E. Light chain shuffling results in successful phage display of antibody fragments to N-glycolyl GM3 ganglioside. J. Immunol. Methods 293 (2004) 71-83
29. Roque-Navarro L., Mateo C., Lombardero J., Mustelier G., Fernández A., Sosa K., Morrison S.L., and Pérez R. Humanization of predicted T-cell epitopes reduces the immunogenicity of chimeric antibodies: new evidence supporting a simple method. Hybrid. Hybridomics 22 (2003) 245-257
30. Sanger F., Nicklen S., and Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U.S.A. 74 (1977) 5463-5467
31. Schaeble K.F., Thiebe R., Bensch A., Brensing-Kueppers J., Heim V., Kirschbaum T., Lamm R., Ohnrich M., Pourrajabi S., Roeschenthaler F., Schwendinger J., Wichelhaus D., Zocher I., and Zachau H.G. Characteristics of the immunoglobulin Vkappa genes, pseudogenes, relics and orphons in the mouse genome. Eur. J. Immunol. 29 (1999) 2082-2086
32. Sepulveda J., Jin H., Sblattero D., Bradbury A., and Burrone O.R. Binders based on dimerised immunoglobulin VH domains. J. Mol. Biol. 333 (2003) 355-365
33. Shlomchik M.J., Marshak-Rothstein A., Wolfowicz C.B., Rothstein T.L., and Weigert M.G. The role of clonal selection and somatic mutation in autoimmunity. Nature 328 (1987) 805-811
34. Stults C.L.M., Sweeley C.C., and Matcher B.A. Glycosphingolipids: structure, biological source, and properties. Methods Enzymol. 179 (1989) 167-214
35. Svennerholm L. The gangliosides. J. Lipid Res. 5 (1964) 145-155
36. Tanha J., Xu P., Chen Z., Ni F., Kaplan H., Narang S.A., and MacKenzie C.R. Optimal design features of camelized human single-domain antibody libraries. J. Biol. Chem. 276 (2001) 24774-24780
37. Vázquez A.M., Alfonso M., Lanne B., Karlsson K.-A., Carr A., Barroso O., Fernández L.E., Rengifo E., Lanio M.E., Alvarez C., Zeuthen J., and Pérez R. Generation of a murine monoclonal antibody specific for N-glycolylneuraminic acid-containing gangliosides that also recognizes sulfated glycolipids. Hybridoma 14 (1995) 551-556
38. Vázquez A.M., Pérez A., Hernández A.M., Macías A., Alfonso M., Bombino G., and Pérez R. Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody. Hybridoma 17 (1998) 527-534
39. Whitelegg N.R.J., and Rees A.R. WAM-an improved algorithm for modelling antibodies on the web. Prot. Eng. 13 (2000) 819-824. http://antibody.bath.ac.uk/
40. Xu J.L., and Davis M.M. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 13 (2000) 37-45